TrialsgrambetaRCTs are beautiful

BPROAD

2025

Blood Pressure Control Targets in Diabetes

In 12,821 patients with type 2 diabetes, intensive blood-pressure control to below 120 mm Hg reduced major cardiovascular events compared with a target below 140 mm Hg.

Result

Efficacy: Major cardiovascular eventsHR 0.79

Below 1 favours intensive blood-pressure control to below 120 mm Hg, above 1 favours a target below 140 mm Hg.

Also reported: (21 % RRR); more hyperkalaemia in the intensive arm.

Original publication
Subtopic
BP target
Design
Open-label RCT
Relevance
Important: one of several pillars.
Source
Bi Y, et al. N Engl J Med. 2025;392(12):1155-1167.doi 10.1056/NEJMoa2412006

Discussion & critique

Overturns the neutral ACCORD-BP result and extends the intensive target to diabetes. Chinese cohort; monitoring for AKI and hyperkalaemia is essential.

Discussed in podcasts